MFS
ATXS

Mirabella Financial Services’s Astria Therapeutics ATXS Stock Holding History

Mirabella Financial Services’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-28,585
Closed -$380K – 489
2023
Q1 		$380K Buy
+28,585
New +$386K 0.06% 248

Other funds holding ATXS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Mirabella Financial Services's ATXS Position: Q2 2023 in Review

Mirabella Financial Services sold out of Astria Therapeutics (ATXS) in Q2 2023, closing a stake of 28,585 shares — an estimated $380K sold.

Mirabella Financial Services first reported a position in ATXS in Q1 2023 and held it in 1 quarter. The position peaked at $380K in Q1 2023. 76 funds tracked by Wall St. Rank hold ATXS as of Q2 2023.

  • Mirabella Financial Services reported no remaining Astria Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Mirabella Financial Services sold 28,585 Astria Therapeutics shares in Q2 2023, an estimated $380K.
  • Mirabella Financial Services first reported a position in Astria Therapeutics in Q1 2023 and held it in 1 quarter.
  • Mirabella Financial Services's Astria Therapeutics position peaked at $380K in Q1 2023.
  • 76 funds tracked by Wall St. Rank held Astria Therapeutics as of Q2 2023.

Based on Mirabella Financial Services's 13F filing for Q2 2023, filed 7 Aug 2023.